TABLE 4.
Plan complexity parameters and dosimetric verification results for MCO auto and clinical manual plans.
| MCS | Delivery time (s) | MU |
γ passing rate (%) (3%/2 mm, global) |
ΔD (%) | |
|---|---|---|---|---|---|
| MCO MFS auto plan (AVG ± 1SD) | 0.29 ± 0.07 | 448 ± 73 | 3379 ± 573 | 91 ± 3 | −1.4 ± 1.4 |
| MCO HFS auto plan (AVG ± 1SD) | 0.40 ± 0.70 | 319 ± 41 | 2368 ± 294 | 96 ± 2 | −0.2 ± 1.7 |
|
Clinical plan (AVG ± 1SD) |
0.37 ± 0.13 | 297 ± 51 | 2146 ± 394 | 96 ± 3 | 0.9 ± 2.0 |
| p MCO MFS vs clinical | <0.01 | <0.01 | <0.01 | 0.3 | 0.06 |
| p MCO HFS vs clinical | 0.7 | 0.2 | 0.02 | 1 | 0.59 |
MFS, Medium Fluence Smoothing; HFS, High Fluence Smoothing; volume; MCS, Modulation Complexity Score; MU, Monitor Units; ΔD, percentage dose difference. In bold the P‐values expressing a statistically significant difference between auto and manual plan at the 0.05 level.